Latest News
6/22/10 Celgene Absolute Bioavailability Data - Poster at ASCPT 2010
Date Posted: |
22 Jun 2010 |
Summary: |
CC-11050 is a novel anti-inflammatory with specific phosphodiesterase type IV (PDE4) inhibition activity. |
Download: |
 Celgene_XceleronNov 09_AAPS Poster.pdf Download |
|
Absolute Bioavailability of CC-11050, a low water soluble NCE, using an IV microdose of [14C]-CC-11050 solution concomitantly with an oral unlabelled dose. The analysis of the trace amount of [14C] labelled parent drug is achieved by AMS.
Poster presented at ASCPT 2010 by Celgene and Quotient Clinical.
Click to see more news
